LY104
LY104 is a candidate compound for the research of chronic obstructive pulmonary disease (COPD) [1].
Product Specifications
UNSPSC
12352005
Target
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Others
Smiles
N=C(NCCCCOC(C1=CC(OCC2CC2)=C(C=C1)OC(F)F)=O)N
Molecular Formula
C17H23F2N3O4
Molecular Weight
371.38
References & Citations
[1]Zhang J, et al. Kilogram-Scale Synthesis and Impurity Profiling of a COPD Candidate LY104: Optimization of Salt Forms for Enhanced Purity and Pharmaceutical Potential[J]. Organic Process Research & Development, 2025.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1204164-01 0.02 mg (E-Coli)
Recombinant Streptococcus pneumoniae UPF0291 protein SPJ_1373 (SPJ_1373)
Ask
View Details MBS1204164-02 0.1 mg (E-Coli)
Recombinant Streptococcus pneumoniae UPF0291 protein SPJ_1373 (SPJ_1373)
Ask
View Details 
MBS1204164-03 0.02 mg (Yeast)
Recombinant Streptococcus pneumoniae UPF0291 protein SPJ_1373 (SPJ_1373)
Ask
View Details 
MBS1204164-04 0.1 mg (Yeast)
Recombinant Streptococcus pneumoniae UPF0291 protein SPJ_1373 (SPJ_1373)
Ask
View Details 
MBS1204164-05 0.02 mg (Baculovirus)
Recombinant Streptococcus pneumoniae UPF0291 protein SPJ_1373 (SPJ_1373)
Ask
View Details MBS1204164-06 1 mg (E-Coli)
Recombinant Streptococcus pneumoniae UPF0291 protein SPJ_1373 (SPJ_1373)
Ask
View Details